| Application no. and date | 20800121.4 (espacenet) (Federated) (European Patent Register), 20201030 | | Patent/reg. no. and date | DK/EP 4051710, 20251126 | | Publication date | 20220907 | | Priority no. and date | EP 19206479, 20191031 | | EP pub. no. and date |
EP 4051710 20220907 | | Effective date | | | Applicant/owner | Incyte Corporation, 1801 Augustine Cut-Off
Wilmington, DE 19803, US | | Applicant ref. no. | V499245DK00 | | Inventor | ENDELL, Jan, Barer Str. 36
80333 München, DE,
BOXHAMMER, Rainer, Birkenstraße 4a
83059 Kolbermoor, DE,
PRETSCHER, Dominik, Schweinfurter Straße 7
97080 Würzburg, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 35/17 (2025.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/02 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTITUMOR-KOMBINATIONSTERAPI BESTÅENDE AF ANTI-CD19-ANTISTOF OG GAMMA-DELTA-T-CELLER | | Int. application no. | EP2020080494 | | Int. publication no. | WO2021084063 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
